Exploring a new treatment for jaw joint disc degeneration
Evaluation of Prg4 as a New Therapy for TMJ Disc Degeneration
This study is looking at how a protein called Prg4 helps keep the jaw joint healthy, and it aims to find out what happens when this protein is missing, which could lead to better treatments for people with jaw pain or TMJ disorders.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Children's Hosp of Philadelphia NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10677033 on NIH RePORTER |
What this research studies
This research investigates the role of a specific protein, Proteoglycan 4 (Prg4), in maintaining the health of the temporo-mandibular joint (TMJ) disc, which is crucial for jaw movement and function. The study aims to understand how the absence of Prg4 affects the structure and function of the TMJ disc, particularly in cases of degeneration and displacement. By using animal models, researchers will analyze changes in the TMJ disc and explore potential therapeutic approaches to restore its function. Patients with TMJ disorders may benefit from insights gained through this research, leading to improved treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing TMJ disorders, particularly those with disc displacement or degeneration.
Not a fit: Patients with TMJ disorders not related to disc issues or those with other underlying conditions affecting the jaw may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that restore the function of the TMJ disc and alleviate symptoms for patients suffering from TMJ disorders.
How similar studies have performed: Previous research has shown promising results in understanding joint lubricants and their role in joint health, suggesting potential for success in this novel approach.
Where this research is happening
Philadelphia, United States
- Children's Hosp of Philadelphia — Philadelphia, United States (Active)
Researchers
- Principal investigator: Koyama, Eiki — Children's Hosp of Philadelphia
- Study coordinator: Koyama, Eiki
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.